The Effects of Aripiprazole on the Processing of Rewards in Schizophrenia

• Status: Terminated
• Trial end date: 2011-04-01
• Target enrollment: 0
• Participant gender: Male

Summary

The objective of this study is to determine whether subjects with negative symptoms of schizophrenia have abnormal functioning of brain circuits relevant to reward processing, and to determine whether any such abnormalities are normalized by treatment with aripiprazole.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Emory University
• Collaborator: Bristol-Myers Squibb
• Treatments: Aripiprazole

Criteria

Subjects with Schizophrenia:

Inclusion Criteria:

• Diagnosed with schizophrenia

• Male

• Age 20-50

• Right handed

Exclusion Criteria:

• No current or past drug or alcohol problems (dependance or abuse)

• Not color blind

Control Subjects:

Inclusion Criteria:

• Male

• Age 20-50

• Right handed

Exclusion Criteria:

• No current psychiatric problems

• No current or past drug or alcohol problems

• Not color blind